News
2h
Zacks Investment Research on MSNHere's Why United Therapeutics (UTHR) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
A genetically engineered pig kidney helped Towana Looney enjoy 130 days without the need for dialysis before the organ was ...
Sangamo Therapeutics, Inc.’s SGMO share price has dipped by 6.63%, which has investors questioning if this is right time to ...
3d
Zacks Investment Research on MSNWill United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.
United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...
A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
In this article, we are going to take a look at where United States Cellular Corporation (NYSE:USM) stands against other telecom stocks that are surging in 2025. The telecom sector has seen many ...
3 Reasons Investors Watch United Therapeutics (UTHR) Over the last six months, United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% ...
1 Day UMC 0.45% DJIA -0.37% S&P 500 -0.33% Technology -2.28% ...
March 27, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq ... It is estimated to affect approximately 1 in 56,500 births in the United States and is the only genetic subtype ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results